News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
493,792 Results
Type
Article (32317)
Company Profile (52)
Press Release (461423)
Multimedia
Podcasts (75)
Webinars (7)
Section
Business (147404)
Career Advice (1770)
Deals (24796)
Drug Delivery (69)
Drug Development (61849)
Employer Resources (115)
FDA (11926)
Job Trends (10763)
News (250181)
Policy (23371)
Tag
2024 BioCapital Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
Academia (2191)
Academic (1)
Accelerated approval (4)
Adcomms (16)
Allergies (58)
Alliances (39447)
ALS (74)
Alzheimer's disease (1209)
Antibody-drug conjugate (ADC) (73)
Approvals (11948)
Artificial intelligence (187)
Autoimmune disease (15)
Automation (12)
Bankruptcy (232)
Best Places to Work (8935)
BIOSECURE Act (7)
Biosimilars (56)
Biotechnology (40)
Bladder cancer (53)
Brain cancer (19)
Breast cancer (208)
Cancer (1640)
Cardiovascular disease (147)
Career advice (1484)
Career pathing (26)
CAR-T (106)
Cell therapy (322)
Cervical cancer (16)
Clinical research (50011)
Collaboration (648)
Compensation (227)
Complete response letters (12)
COVID-19 (1858)
CRISPR (34)
C-suite (149)
Cystic fibrosis (76)
Data (1764)
Decentralized trials (2)
Denatured (24)
Depression (28)
Diabetes (223)
Diagnostics (4635)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (38)
Drug discovery (94)
Drug pricing (70)
Drug shortages (23)
Duchenne muscular dystrophy (80)
Earnings (63257)
Editorial (30)
Employer branding (14)
Employer resources (101)
Events (74031)
Executive appointments (491)
FDA (12833)
Featured Employer (22)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (518)
Gene editing (79)
Generative AI (21)
Gene therapy (265)
GLP-1 (575)
Government (3302)
Grass and pollen (3)
Guidances (41)
Healthcare (14295)
Huntington's disease (16)
IgA nephropathy (23)
Immunology and inflammation (77)
Indications (23)
Infectious disease (1965)
Inflammatory bowel disease (101)
Inflation Reduction Act (8)
Influenza (36)
Intellectual property (74)
Interviews (312)
IPO (12358)
IRA (29)
Job creations (2194)
Job search strategy (1254)
Kidney cancer (7)
Labor market (21)
Layoffs (280)
Leadership (16)
Legal (5567)
Liver cancer (45)
Lung cancer (233)
Lymphoma (113)
Machine learning (2)
Management (38)
Manufacturing (193)
MASH (69)
Medical device (9500)
Medtech (9504)
Mergers & acquisitions (12892)
Metabolic disorders (558)
Multiple sclerosis (58)
NASH (20)
Neurodegenerative disease (69)
Neuropsychiatric disorders (17)
Neuroscience (1612)
NextGen: Class of 2025 (4798)
Non-profit (3581)
Northern California (1869)
Now hiring (30)
Obesity (278)
Opinion (180)
Ovarian cancer (52)
Pain (74)
Pancreatic cancer (59)
Parkinson's disease (107)
Partnered (16)
Patents (165)
Patient recruitment (82)
Peanut (31)
People (38334)
Pharmaceutical (12)
Pharmacy benefit managers (10)
Phase I (15087)
Phase II (22017)
Phase III (16956)
Pipeline (960)
Policy (85)
Postmarket research (2199)
Preclinical (6840)
Press Release (41)
Prostate cancer (89)
Psychedelics (23)
Radiopharmaceuticals (207)
Rare diseases (293)
Real estate (3347)
Recruiting (42)
Regulatory (16038)
Reports (25)
Research institute (1823)
Resumes & cover letters (276)
Rett syndrome (4)
RNA editing (2)
RSV (33)
Schizophrenia (60)
Series A (82)
Series B (53)
Service/supplier (4)
Sickle cell disease (40)
Southern California (1649)
Special edition (7)
Spinal muscular atrophy (101)
Sponsored (20)
Startups (2271)
State (1)
Stomach cancer (9)
Supply chain (37)
Tariffs (10)
The Weekly (50)
United States (16425)
Vaccines (482)
Venture capitalists (19)
Weight loss (184)
Women's health (20)
Worklife (12)
Date
Last 7 days (361)
Last 30 days (1849)
Last 365 days (25311)
2025 (6872)
2024 (26872)
2023 (30154)
2022 (38013)
2021 (41136)
2020 (39963)
2019 (34544)
2018 (26021)
2017 (24146)
2016 (23286)
2015 (27347)
2014 (21917)
2013 (18668)
2012 (19081)
2011 (18739)
2010 (17550)
Location
Africa (628)
Alabama (42)
Alaska (4)
Arizona (113)
Arkansas (8)
Asia (27498)
Australia (4872)
California (4233)
Canada (1410)
China (370)
Colorado (189)
Connecticut (210)
Delaware (93)
Europe (63314)
Florida (670)
Georgia (166)
Idaho (33)
Illinois (382)
India (19)
Indiana (243)
Iowa (4)
Japan (119)
Kansas (77)
Kentucky (12)
Louisiana (6)
Maine (59)
Maryland (625)
Massachusetts (3096)
Michigan (160)
Minnesota (238)
Mississippi (2)
Missouri (45)
Montana (16)
Nebraska (17)
Nevada (45)
New Hampshire (49)
New Jersey (1341)
New Mexico (16)
New York (1292)
North Carolina (757)
North Dakota (4)
Northern California (1869)
Ohio (153)
Oklahoma (11)
Oregon (25)
Pennsylvania (979)
Puerto Rico (5)
Rhode Island (21)
South America (884)
South Carolina (15)
South Dakota (1)
Southern California (1649)
Tennessee (82)
Texas (647)
Utah (131)
Virginia (107)
Washington D.C. (43)
Washington State (424)
West Virginia (2)
Wisconsin (33)
493,792 Results for "crg and associates llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock - May 14, 2024
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced that entities affiliated with CRG Servicing LLC have converted Series A and Series B Convertible Preferred Stock to Common Stock.
May 14, 2024
·
4 min read
Genetown
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc. announced the entrance into a definitive agreement to convert $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity upon stockholder approval.
February 15, 2024
·
5 min read
Genetown
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of an additional $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity.
May 6, 2024
·
4 min read
Biotech Bay
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
Avinger, Inc. announced the conversion of $11 million or approximately 80% of its existing debt with entities affiliated with CRG Partners III L.P. into a shares of a new series of convertible preferred stock.
May 16, 2024
·
3 min read
Press Releases
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
November 5, 2024
·
10 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
Genetown
T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of approximately 20% of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems common stock and Series B convertible preferred stock.
July 6, 2023
·
4 min read
Press Releases
PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution
March 25, 2025
·
3 min read
Press Releases
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
April 2, 2025
·
6 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
1 of 49,380
Next
